ALPMF - Merck's Keytruda cuts bladder cancer risk by 31% in Phase 3 trial
2024-01-26 12:58:45 ET
More on Merck
- Merck & Co., Inc. (MRK) JPMorgan 42nd Annual Healthcare Conference (Slides)
- Merck & Co., Inc. (MRK) Presents at JPMorgan 42nd Annual Healthcare Conference (Transcript)
- Merck's Soaring Stock: Examining The Euphoria Amidst Potential Pitfalls
- Dividend Roundup: Merck, Costco, Lockheed Martin, Comcast, and more
- LAVA stock rises on clinical trial collaboration with Merck